Summary
Updated Aug 30, 2026
David-Alexandre C. Gros is Chief Executive Officer, Director of Eledon Pharmaceuticals, Inc. (ELDN). 2 SEC Form 4 filings on record going back to 2024, most recently on 4 August 2026.
Recent Transactions
2Every recent SEC Form 4 transaction David-Alexandre C. Gros has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as David-Alexandre C. Gros. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BVF PARTNERS L P - $17.35M of ELDN open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is David-Alexandre C. Gros?
David-Alexandre C. Gros is a corporate insider, tracked as Chief Executive Officer, Director of Eledon Pharmaceuticals, Inc. (ELDN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David-Alexandre C. Gros submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of David-Alexandre C. Gros's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow David-Alexandre C. Gros and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
